Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06376175 · ClinicalTrials.gov registry record
Task Atlas: Study to Develop a Task Atlas of Brain Recruitment During a Digital Game-based Program
A clinical trial, sponsored by Lumos Labs.
- Completed
- Registry status
- 37
- Enrollment target
NCT06376175: Completed study, sponsored by Lumos Labs.
NCT06376175 is a clinical trial that has completed, run by Lumos Labs. The registered enrollment target is 37 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06376175 has completed, sponsored by Lumos Labs.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
Study Summary
Healthy volunteers ages 25-40 from the general US population who meet the eligibility criteria and are enrolled will (a) play Lumosity games at least 20 times each in under 60 days and (b) then complete one session of task-based functional magnetic resonance imaging (fMRI) while playing Lumosity games.
Primary Outcome
Whole-brain blood oxygen level-dependent (BOLD) response during gameplay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2024-04-24 |
| Est. Completion | 2025-01-15 |
What the finished NCT06376175 record still lists
NCT06376175 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 37 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT06376175 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06376175 about?
NCT06376175 is a clinical study titled "Task Atlas: Study to Develop a Task Atlas of Brain Recruitment During a Digital Game-based Program". Healthy volunteers ages 25-40 from the general US population who meet the eligibility criteria and are enrolled will (a) play Lumosity games at least 20 times each in under 60 days and (b) then complete one session of task-based functional magnetic resonance imaging (fMRI) while playing Lumosity gam...
What is the current status of trial NCT06376175?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2024-04-24. Estimated completion is 2025-01-15.
Who is sponsoring clinical trial NCT06376175?
This trial is sponsored by Lumos Labs, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI